A team of researchers at Wistar’s Ellen and Ronald Caplan Cancer Center has identified a gene signature that accurately predicts the functioning of P53 variants—important for assessing cancer risk and optimizing choices for cancer therapeutics.
Jozef Madzo was named director of bioinformatics at the Wistar Institute. He will lead and oversee Wistar’s bioinformatics projects and initiatives across a variety of advanced biomedical research programs.
